Pharma and diagnostic investor Conviction Life files for IPO
Advertisement
London: Diagnostics and pharmaceutical services technologies investor Conviction Life has filed for an initial public offering to trade on the main market of the London Stock Exchange, the company said on Friday.
Conviction Life is targeting gross proceeds of up to 100 million pounds ($121 million) through the issue of up to 100 million ordinary shares.
The company will also undertake a placing programme for up to 250 million ordinary shares and plans to start trading on Dec. 16.
Read also: Concord Biotech files IPO papers with SEBI
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.